465 related articles for article (PubMed ID: 35198928)
1. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis.
Wong GL; Hui VW; Tan Q; Xu J; Lee HW; Yip TC; Yang B; Tse YK; Yin C; Lyu F; Lai JC; Lui GC; Chan HL; Yuen PC; Wong VW
JHEP Rep; 2022 Mar; 4(3):100441. PubMed ID: 35198928
[TBL] [Abstract][Full Text] [Related]
2. Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B.
Yip TC; Wong GL; Wong VW; Tse YK; Liang LY; Hui VW; Lee HW; Lui GC; Chan HL
J Hepatol; 2020 May; 72(5):847-854. PubMed ID: 31857194
[TBL] [Abstract][Full Text] [Related]
3. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
4. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.
Yip TC; Wong GL; Chan HL; Tse YK; Lam KL; Lui GC; Wong VW
J Hepatol; 2019 Mar; 70(3):361-370. PubMed ID: 30367899
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase.
Zhan J; Wang J; Zhang Z; Xue R; Jiang S; Liu J; Liu Y; Zhu L; Xia J; Yan X; Ding W; Zhu C; Qiu Y; Li J; Huang R; Wu C
Virulence; 2023 Dec; 14(1):2268497. PubMed ID: 37938933
[TBL] [Abstract][Full Text] [Related]
6. Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B.
Papatheodoridis GV; Dalekos GN; Idilman R; Sypsa V; Van Boemmel F; Buti M; Calleja JL; Goulis J; Manolakopoulos S; Loglio A; Papatheodoridi M; Gatselis N; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Yurdaydin C; Esteban R; Janssen HLA; Berg T; Lampertico P
JHEP Rep; 2021 Jun; 3(3):100290. PubMed ID: 34041470
[TBL] [Abstract][Full Text] [Related]
7. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
8. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
9. Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.
Hsu YC; Yip TC; Ho HJ; Wong VW; Huang YT; El-Serag HB; Lee TY; Wu MS; Lin JT; Wong GL; Wu CY
J Hepatol; 2018 Aug; 69(2):278-285. PubMed ID: 29551708
[TBL] [Abstract][Full Text] [Related]
10. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI
JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699
[TBL] [Abstract][Full Text] [Related]
11. Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy.
Nam JY; Sinn DH; Bae J; Jang ES; Kim JW; Jeong SH
JHEP Rep; 2020 Dec; 2(6):100175. PubMed ID: 33117971
[TBL] [Abstract][Full Text] [Related]
12. Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States.
Kim HS; Yu X; Kramer J; Thrift AP; Richardson P; Hsu YC; Flores A; El-Serag HB; Kanwal F
J Hepatol; 2022 Feb; 76(2):294-301. PubMed ID: 34563579
[TBL] [Abstract][Full Text] [Related]
13. Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC.
Hui VW; Chan SL; Wong VW; Liang LY; Yip TC; Lai JC; Yuen BW; Luk HW; Tse YK; Lee HW; Chan HL; Wong GL
JHEP Rep; 2020 Dec; 2(6):100152. PubMed ID: 33024950
[TBL] [Abstract][Full Text] [Related]
14. Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment.
Gokcen P; Guzelbulut F; Adali G; Degirmenci Salturk AG; Ozturk O; Bahadir O; Kanatsiz E; Kiyak M; Ozdil K; Doganay HL
World J Gastroenterol; 2022 Feb; 28(6):665-674. PubMed ID: 35317422
[TBL] [Abstract][Full Text] [Related]
15. HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics.
Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
J Hepatol; 2016 Jul; 65(1):48-56. PubMed ID: 27034253
[TBL] [Abstract][Full Text] [Related]
16. Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma.
Wong GL; Tse YK; Chan HL; Yip TC; Tsoi KK; Wong VW
Aliment Pharmacol Ther; 2016 Apr; 43(7):802-13. PubMed ID: 26843444
[TBL] [Abstract][Full Text] [Related]
17. Twelve-month post-treatment parameters are superior in predicting hepatocellular carcinoma in patients with chronic hepatitis B.
Ahn SB; Choi J; Jun DW; Oh H; Yoon EL; Kim HS; Jeong SW; Kim SE; Shim JJ; Cho YK; Lee HY; Han SW; Nguyen MH;
Liver Int; 2021 Jul; 41(7):1652-1661. PubMed ID: 33550661
[TBL] [Abstract][Full Text] [Related]
18. Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients.
Yip TC; Wong VW; Lai MS; Lai JC; Tse YK; Liang LY; Hui VW; Chan HL; Wong GL
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2864-2875.e16. PubMed ID: 36828301
[TBL] [Abstract][Full Text] [Related]
19. Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
Audureau E; Carrat F; Layese R; Cagnot C; Asselah T; Guyader D; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Chazouillères O; Mallat A; Grangé JD; Attali P; d'Alteroche L; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Pol S; Nahon P;
J Hepatol; 2020 Dec; 73(6):1434-1445. PubMed ID: 32615276
[TBL] [Abstract][Full Text] [Related]
20. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.
Fan R; Papatheodoridis G; Sun J; Innes H; Toyoda H; Xie Q; Mo S; Sypsa V; Guha IN; Kumada T; Niu J; Dalekos G; Yasuda S; Barnes E; Lian J; Suri V; Idilman R; Barclay ST; Dou X; Berg T; Hayes PC; Flaherty JF; Zhou Y; Zhang Z; Buti M; Hutchinson SJ; Guo Y; Calleja JL; Lin L; Zhao L; Chen Y; Janssen HLA; Zhu C; Shi L; Tang X; Gaggar A; Wei L; Jia J; Irving WL; Johnson PJ; Lampertico P; Hou J
J Hepatol; 2020 Dec; 73(6):1368-1378. PubMed ID: 32707225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
